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Edited by Vladimir SkulachevAbstract Herein, we report cloning and subcellular localization
of two alanine aminotransferase (ALT) isozymes, cALT and
mALT, from liver of gilthead sea bream (Sparus aurata). CHO
cells transfected with constructs expressing cALT or mALT as
C- or N-terminal fusion with the enhanced green ﬂuorescent
protein (EGFP) showed that cALT is cytosolic, whereas mALT
localized to mitochondria. Fusion of EGFP to mALT N-
terminus or removal of amino acids 1–83 of mALT avoided
import into mitochondria, supporting evidence that the mALT N-
terminus contains a mitochondrial targeting signal. The amino
acid sequence of mALT is the ﬁrst reported for a mitochondrial
ALT in animals.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Alanine aminotransferase (ALT, EC 2.6.1.2) plays an im-
portant role in amino acid metabolism and gluconeogenesis by
catalyzing reversible transamination between L-alanine and a-
keglutarate to form pyruvate and L-glutamate [1]. In mam-
mals, ALT activity is found in liver, muscle, heart, kidney,
brain and adipose tissue. The presence of two soluble ALT
enzymes, cytosolic and mitochondrial, has been suggested on
the basis of biochemical studies [2,3], even though the func-
tional role of ALT isozymes remains unclear. Since mamma-
lian ALT cytosolic activity is predominant in glycolytic tissues
and shows lower aﬃnity for L-alanine, it was hypothesized as
being mainly involved in the conversion of pyruvate to L-
alanine. On the other hand, mitochondrial ALT exhibits
higher aﬃnity for L-alanine and was considered to be mainlyq Nucleotide sequence data reported are available in the DDBJ/
EMBL/GenBank databases under the accession numbers AY206502
(cALT) and AY206503 (mALT).
qq Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2004.04.051.
* Corresponding author. Fax: +34-93-402-45-20.
E-mail address: baanantevazquez@ub.edu (I.V. Baanante).
Abbreviations: ALT, alanine aminotransferase; EGFP, enhanced green
ﬂuorescent protein; LDH, lactate dehydrogenase; SDH, succinate
dehydrogenase
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have shown a signiﬁcant contribution of ALT reaction in
glutamate oxidation by rat liver mitochondria and that a part
of alanine-derived pyruvate originates in the cytoplasm. Fur-
thermore, contribution of rat liver mitochondrial ALT activity
during gluconeogenesis was considered negligible compared
with that of the cytoplasmic isozyme [5]. Based on the amino
acid sequence of liver cytosolic ALT [6], the human ALT1 gene
has been cloned and mapped to human chromosome 8q24.3
[7]. Recently, Yang and co-workers [8] cloned another human
ALT isozyme, ALT2, and mapped this gene to chromosome
16q12.1. At present, no data are available regarding subcel-
lular localization of ALT2.
To gain insight of the molecular machinery involved in
amino acid metabolism, we cloned and addressed subcellular
localization of two ALT isoforms from the liver of gilthead sea
bream (Sparus aurata).2. Materials and methods
2.1. Molecular cloning of cALT and mALT from the liver of S. aurata
RT-PCR experiments were carried out with total RNA from liver of
S. aurata. The synthesized cDNA was used as a template for PCR
using primers IMAL03, IMAL04 and IMAL10 (Table 1), which cor-
respond to conserved regions in rat and human liver cytosolic ALT.
PCR products were ligated into pGEM T easy (Promega) and se-
quenced using ABI Prism BigDye Terminator Cycle Sequencing
Ready Reaction Kit (Applied Biosystems). Sequence analysis revealed
cloning of two isozymes, named cALT and mALT, and was thereafter
used to design oligonucleotides (Table 1) to obtain full-length cDNAs
coding for cALT and mALT by performing RACE experiments with
SMART RACE cDNA Ampliﬁcation Kit (Clontech). DNA frag-
ments generated by RACE PCR were ligated into pGEM T easy and
sequenced on both strands. RT-PCR allowed ampliﬁcation of the open
reading frame of cALT and mALT using primer pairs IMAL19/
IMAL20 and IMAL23/IMAL24, respectively (Table 1). The resulting
products were ligated into pGEM T easy to generate pGEM-cALT
and pGEM-mALT.
2.2. Fusion protein constructs
To assess subcellular localization of cALT and mALT, the complete
coding sequence of both cDNAs was ampliﬁed by PCR and fused to
the enhanced green ﬂuorescent protein (EGFP). cALT was ampliﬁed
using primer pairs IMAL18/IMAL20 and IMAL19/IMAL21 (Table
1), whereas mALT was ampliﬁed using primer pairs IMAL22/IMAL24
and IMAL23/IMAL25 (Table 1), to clone the generated fragments
either into pEGFP-C3 or pEGFP-N1 (Clontech). The pGFP-cALT
and pGFP-mALT constructs were generated by ligation of the corre-
sponding ampliﬁed product into pEGFP-C3, previously digested with
EcoRI and BamHI. Digestion of PCR products and pEGFP-N1 with
NheI and BamHI allowed ligation and generation of pcALT-GFP andblished by Elsevier B.V. All rights reserved.
Table 1
Primers used in the present study
Primer (50 to 30) Maps to
IMAL03 CATCAACCCAGGAAACCCCAC cALT, 813–833
IMAL04 ACATGGCTCCCTGCACTGGG cALT, 1333–1314
IMAL07 CAGCCCTCTGCGTACACATTATCCTG cALT, 947–922
IMAL08 GAAGGAACGGACAGCAGTGTTAGCAGAG cALT, 1224–1251
IMAL09 GCAGAGAAGGCCAGGCTAACAGAGCAG cALT, 1254–1281
IMAL10 GCTGACTGTTGACACCATGAAC cALT, 156–177
IMAL11 CCGCTCGCTGGACTACGGGACCACGA cALT, 207–232
IMAL12 TAGCCCGCTGCACGATGGGCCCCCGC mALT, 408–383
IMAL13 CGAGCTGCAGCGCTCTCTGGACGAG mALT, 928–953
IMAL14 CGGCAACACTGCAACCCCCGAGC mALT, 957–979
IMAL15 CCCTCCCTCAGCTCCTTCTCTATCTGC cALT, 260–234
IMAL17 CAGCAGTTCAGGGTAGGAGCAGAGC mALT, 557–533
IMAL18 GAGAATTCTGTCCCACCAGGCGGCGAACG cALT, 113–133
IMAL19 GAGCTAGCCAACATGTCCCACCAGGCGGCG cALT, 108–129
IMAL20 GAGGATCCTGGGGTTGTTATGAGAACTCTTG cALT, 1595–1573
IMAL21 GAGGATCCCGTGAGAACTCTTGTGTGAAGCG cALT, 1584–1563
IMAL22 GAGAATTCTGTCGGCTACAAGGATGCAG mALT, 100–119
IMAL23 GAGCTAGCCAACATGTCGGCTACAAGGATG mALT, 96–116
IMAL24 GAGGATCCATTTAAGAATACTGCTGAGTGAAC mALT, 1766–1742
IMAL25 GAGGATCCCGAGAATACTGCTGAGTGAACTTC mALT, 1760–1739
IMAL28 GAGTTCCACTCCTGTCGAGTG mALT, 1–21
IMAL29 CTTCTCTTTGGGGAGCCCGC mALT, 296–277
The following primers contain restriction sites (bold and underlined): IMAL18 and IMAL22 EcoRI; IMAL19 and IMAL23 NheI; IMAL20,
IMAL21, IMAL24 and IMAL25 BamHI.
Mapping positions are calculated from S. aurata cALT and mALT cDNAs.
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mALT as a C- or N-terminal fusion with EGFP. pmALTD83-GFP
was obtained by deletion of 83 amino acids at the N-terminal region of
mALT. For this, pmALT-GFP was digested with NheI and SmaI;
following puriﬁcation and end ﬁlling-in, the resulting major band was
religated. All constructs were checked by cycle sequencing.
2.3. Expression in CHO cells and confocal ﬂuorescence microscopy
CHO cells grown on glass coverslips in Ham’s F-12 Nutrient Mix-
ture (Invitrogen), supplemented with 10% fetal bovine serum at 37 C
under 5% CO2, were transiently transfected with the various GFP-
fusion protein constructs using FuGene 6 (Roche), according to the
manufacturer’s instructions. For mitochondrial staining, 1 lM Mito-
Tracker Red CM-H2XRos (Molecular Probes, Eugene, OR) was
added to medium for 45 min at 37 C at 48 h post-transfection. The
cells were ﬁxed with 4% paraformaldehyde and mounted in Mowiol
(Aldrich). The cells were examined by sequential excitation at 488 nm
(EGFP) and 543 nm (MitoTracker) by laser scanning confocal ﬂuo-
rescence microscopy (Olympus Fluoview FV600, Olympus, Middlesex,
UK) with a PLAN APO 100 1.40 oil objective (Olympus). The
images were acquired and merged by using the Fluoview application
software (Olympus).
2.4. Subcellular fractionation of CHO cells
Subcellular fractionation of CHO cells transfected with constructs
pGFP-cALT, pcALT-GFP, pGFP-mALT, pmALT-GFP or
pmALTD83-GFP, was performed using the Subcellular Proteome
Extraction Kit (Calbiochem). Proteins in cytosolic, mitochondrial,
nucleic and cytoskeleton fractions were solubilized in SDS buﬀer and
separated on 10% SDS–PAGE gels. Proteins were transferred to nylon
membranes and immunoblotted with a rabbit polyclonal anti-GFP
(Clontech, diluted 1:100). An anti-rabbit peroxidase-conjugated sec-
ondary antibody was used for chemiluminescent detection with Su-
perSignal West Dura Kit (Pierce). To conﬁrm the quality of subcellular
fractionation, we performed assays for cytosolic (lactate dehydroge-
nase, LDH) and mitochondrial (succinate dehydrogenase, SDH)
marker activities. LDH was assayed using a kit from Linear Chemi-
cals. The activity of SDH was measured according to Dumas et al. [9].
2.5. Subcellular fractionation of S. aurata liver extracts
Mitochondrial fractions were prepared, at 4 C, from liver homog-
enized (1/5, w/v) in buﬀer A (50 mM Tris–HCl, pH 7.5, 0.5 mM
EDTA, 50 mM NaF, 0.5 mM PMSF, 1 mM DTT, 200 mM mannitol
and 70 mM sucrose). To remove nuclear and cell debris, the homog-enate was centrifuged at 500 g for 10 min. The mitochondrial frac-
tion was pelleted by centrifugation at 9000 g for 20 min. The
resulting supernatant contained the cytosolic fraction. The pellet was
washed twice with buﬀer A, resuspended in the same buﬀer and mi-
tochondria were disrupted using a Dounce homogenizer. ALT activity
in cytosolic and mitochondrial fractions was determined at 30 C [10].
LDH and SDH were assayed to conﬁrm the quality of the isolated
fractions.
2.6. Northern blotting analysis
Total RNA was isolated from S. aurata liver using Total Quick
RNA Cells & Tissues Kit (Talent), electrophoresed on a 1% agarose
gel containing 4.75% formaldehyde, transferred to a nylon membrane
and hybridized with homologous probes for cytosolic and mitochon-
drial ALT. The probes were labelled by incorporation of digoxigenin-
11-dUTP during PCR with primer pairs IMAL10/IMAL07 or
IMAL28/IMAL29 (Table 1) and pGEM-cALT or pGEM-mALT, re-
spectively, as template. Labelled probes were immunodetected with
anti-digoxigenin conjugated to alkaline phosphatase and CDP-Star
(Roche) as chemiluminiscent substrate.3. Results and discussion
3.1. Molecular cloning of S. aurata liver cDNAs encoding cALT
and mALT
RT-PCR and RACE PCR approaches allowed us to clone
two ALT isozymes from the liver of S. aurata, named cALT
and mALT. The 2018-bp cALT cDNA contains a 1476-bp
ORF, whereas the 2349-bp mALT cDNA includes a 1665-bp
ORF. A consensus polyadenylation-like signal (ATTAAA) is
found 19 bp and 15 bp upstream the cALT and mALT
poly(Aþ) tails, respectively. The deduced amino acid sequences
of cALT and mALT ORFs predict polypeptides of 491 and
554 amino acids with calculated molecular masses of 54.865
and 61.161 kDa, respectively. The ﬁsh liver cALT and mALT
proteins share an identity of 78%. Alignment of the inferred
peptide sequences of S. aurata liver cALT and mALT with
human and rat ALT1 and human ALT2 gave an identity of
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similarity with mammalian ALTs suggests a high degree of
conservation of the structure and conceivably the reaction
mechanism during vertebrate evolution. Highest sequence di-
vergence was observed within the N-terminal region of mALT,
being 31, 58 and 63 amino acids longer than human ALT2,
human and rat ALT1 and cALT, respectively. Lys313 in the
rat liver cytosolic ALT has been suggested to reside in the
active site and to participate in binding to the coenzyme pyr-
idoxal-50-phosphate [6,11]. This residue is conserved in both
cytosolic and mitochondrial ALT proteins in S. aurata and
corresponds to Lys309 and Lys372, respectively, in the ﬁsh
isozymes. Recently, glycation of Lys313 in the mammalian
cytosolic ALT has been suggested that may contribute to an
inhibitory eﬀect on ALT activity [12]. However, it remains
unclear whether post-translational modiﬁcations have any
regulatory implication in ALT function. Computer analysis
with MitoProt II 1.0a4 [13] pointed to a probability of 98.36%
that mALT cDNA encodes a protein that localizes to mito-
chondria, containing a putative cleavage site at position 70.
Using PSORT II algorithm [14], cALT was predicted to be
cytoplasmic. Consistent with the size of cALT and mALT
cDNA sequences, Northern blots carried out using homolo-
gous probes for S. aurata cALT and mALT showed hybrid-
ization to single bands of about 2.1 and 2.4 kb, respectively
(Fig. 1a).
3.2. Subcellular localization of cALT and mALT isozymes
The activity of ALT isoforms in vivo was analyzed in sub-
cellular fractions of S. aurata liver extracts. Distribution of
ALT activity indicated that more than 85% of total ALT ac-
tivity localized to cytosolic fraction, whereas mitochondrial
ALT corresponded to about 14% of total ALT activity
(Fig. 1b). Subcellular localization of the two proteins cloned
from the liver of S. aurata, cALT and mALT, was examined
with EGFP-fusion proteins in transiently transfected CHO
cells by means of confocal ﬂuorescence microscopy. To de-
termine whether cALT and mALT behave as cytosolic andFig. 1. Northern blots of cALT and mALT, and in vivo ALT activity
in subcellular fractions of S. aurata liver extracts. (a) Representative
Northern blots of cALT and mALT in S. aurata liver. 20 lg of total
hepatic RNA was loaded. (b) ALT, LDH and SDH activities in
cytosolic and mitochondrial fractions from the liver of S. aurata.
Percentage of activity in each fraction is presented as means
S.D. (n ¼ 5–11).mitochondrial proteins, respectively, EGFP was fused to the
N- and C-terminus of both proteins. Irrespective of the posi-
tion of EGFP, cALT showed a diﬀuse distribution in the cells,
indicating cytosolic localization (Fig. 2). The mALT-GFP fu-
sion protein exhibited colocalization with the mitochondrial
marker MitoTracker. This result denoted mitochondrial lo-
calization of mALT. In contrast, GFP-mALT showed a dif-
fused distribution and did not colocalize with MitoTracker,
suggesting that fusion of EGFP to the N-terminus of mALT
blocked entry into mitochondria (Fig. 3). The subcellular lo-
calization of the EGFP-fusion proteins was conﬁrmed by im-
munodetection of EGFP in cytosolic, mitochondrial, nucleic
and cytoskeleton fractions obtained from transiently trans-
fected CHO cells (Fig. 4). Remarkably, immunodetection of
CHO cells transfected with mALT-GFP revealed that the
protein was mostly found in the mitochondrial fraction and to
a lesser extent in cytosol. The fact that mALT-GFP associated
to the mitochondrial fraction exhibited a lower molecular
weight than the protein immunodetected in cytosol argues for
protein import and processing into mitochondria. Our ﬁndings
are consistent with kinetic and chromatographic studies that
indicate the presence of ALT isozymes in cytosol and mito-
chondria [2,3]. Indeed, mALT is the ﬁrst amino acid sequence
reported for a mitochondrial ALT in animals.
3.3. The amino terminus of mALT contains a mitochondrial
targeting signal
The N-terminus of mALT comprises 12 positively charged,
17 hydroxylated and many hydrophobic residues within the
ﬁrst 70 amino acids. It fulﬁlls the physicochemical properties
expected for a mitochondrial targeting signal presequence:
enrichment in positively charged, hydroxylated and hydro-
phobic residues to usually form an amphiphilic secondary
structure [15–20]. According to the ‘‘acid chain hypothesis’’,
the basic N-terminal presequences are directed into mito-
chondria through interaction with translocases of the outerFig. 2. Cytosolic localization of cALT. CHO cells grown on coverslips
were transiently transfected with either pGFP-cALT (a–c) or pcALT-
GFP (d–f), cultured for 48 h and stained with the mitochondrial
marker MitoTracker Red CM-H2XRos. (a,d) Green ﬂuorescence
from EGFP; (b,e) red ﬂuorescence from CM-H2XRos staining; (c,f)
merged images. Bar, 10 lm.
Fig. 4. Immunodetection of EGFP in subcellular fractions of CHO
cells transfected with pGFP-cALT, pcALT-GFP, pGFP-mALT,
pmALT-GFP or pmALTD83-GFP. Following sequential extraction of
cytosolic (1), mitochondrial (2), nucleic (3) and cytoskeleton fractions
(4), proteins were analyzed by SDS–PAGE and immunodetection was
performed using anti-GFP antibody (left part of the ﬁgure). Percentage
of cytosolic and mitochondrial marker activities LDH and SDH, re-
spectively, represented in the right part of the ﬁgure, was assayed in
each fraction.
Fig. 3. The N-terminus of mALT contains a mitochondrial target
signal. CHO cells were grown on coverslips, transiently transfected
with pGFP-mALT (a–c), pmALT-GFP (d–f) or pmALTD83-GFP (g–
i), cultured for 48 h and stained with the mitochondrial marker Mi-
toTracker Red CM-H2XRos. (a,d,g) Green ﬂuorescence from EGFP;
(b,e,h), red ﬂuorescence from CM-H2XRos staining; (c,f,i), merged
images. Bar, 10 lm.
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respectively [21,22]. To further investigate the involvement of
N-terminus of mALT in the subcellular localization of the
protein, CHO cells were transiently transfected with a con-
struct expressing a fusion of EGFP to the C-terminus of
mALT lacking 83 amino acids of the N-terminal end
(pmALTD83-GFP). The resulting polypeptide exhibited a
diﬀuse distribution in the cells and did not colocalize with
MitoTracker (Fig. 3). Immunodetection of EGFP in cytosolic,
mitochondrial, nucleic and cytoskeleton fractions conﬁrmed
that mALTD83-GFP localized to cytosol (Fig. 4). Thus, re-
moval of the N-terminus of mALT avoided entry of the pro-
tein into mitochondria and conﬁrmed that amino acids 1–83 of
mALT contain a mitochondrial targeting signal that is neces-
sary for import into mitochondria.
Availability of nucleotide sequences of ALT isoforms will be
useful to analyze modulation of cytosolic and mitochondrial
ALT expression in diﬀerent nutritional conditions and clinical
disorders associated to high ALT activity levels, such as
obesity, muscle diseases and diabetes. Future studies are nee-
ded to examine kinetic properties of cytosolic and mitochon-
drial ALT and clarify the link between structure, localization
and function of ALT isozymes.
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